Both retinoic acid and 1,25(OH)2 vitamin D3 inhibit thyroid hormone‐induced terminal differentiaton of growth plate chondrocytes
Open Access
- 1 January 2001
- journal article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 19 (1) , 43-49
- https://doi.org/10.1016/s0736-0266(00)00024-3
Abstract
Thyroid hormone has been known for over 50 years to be a potent regulator of skeletal maturation at the growth plate. The receptor for thyroid hormone has been discovered to be a member of the nuclear hormone receptor superfamily. Retinoic acid and 1,25(OH)2 vitamin D3, whose receptors also belong to this nuclear hormone receptor family, have been implicated in the control of chondrocyte proliferation and differentiation at the growth plate. Recent studies demonstrate that the receptors for thyroid hormone, retinoic acid, and vitamin D bind to a similar DNA response element in the promoter region of target genes and may form heterodimers to regulate gene transcription in target cells. These observations led us to hypothesize that the retinoic acid and/or vitamin D signaling pathways may interact with thyroid hormone signaling at the molecular level to modulate growth plate chondrocyte differentiation. Using a chemically defined, serum‐free model of growth plate chondrocyte maturation, both all‐trans retinoic acid and 1,25(OH)2 vitamin D3 markedly inhibited thyroid hormone‐induced terminal differentiation in a dose‐dependent manner. In the absence of thyroid hormone, retinoic acid stimulated alkaline phosphatase activity modestly at the highest dose used, however neither retinoic acid nor 1,25(OH)2 vitamin D3 induced expression of type X collagen mRNA. We conclude that retinoic acid and vitamin D are likely to be antagonists of thyroid hormone signaling in the growth plate. © 2001 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.Keywords
This publication has 46 references indexed in Scilit:
- Bone morphogenetic protein‐7 in growth‐plate chondrocytes: Regulation by retinoic acid is dependent on the stage of chondrocyte maturationJournal of Orthopaedic Research, 1998
- Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factorsMolecular Endocrinology, 1994
- Nongenomic regulation of extracellular matrix events by vitamin D metabolitesJournal of Cellular Biochemistry, 1994
- 24,25-Dihydroxyvitamin D3 Antagonizes Some of the Actions of 1,25-Dihydroxyvitamin D3Biochemical and Biophysical Research Communications, 1994
- Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF‐βJournal of Cellular Physiology, 1994
- Hypertrophic chondrocytes undergo further differentiation in cultureThe Journal of cell biology, 1992
- Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signallingNature, 1992
- Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptorsCell, 1991
- Comparative Morphological and Biochemical Analysis of Hypertrophic, Non-Hypertrophic and L, 25(Oh)2d3Treated Non-Hypertrophic ChondrocytesConnective Tissue Research, 1990
- Retinoic acid rapidly reduces cartilage matrix synthesis by altering gene transcription in chondrocytesDevelopmental Biology, 1987